CEP55 and familial pancreatic carcinoma: Peng et al. (2017) reported that CEP55 expression was an independent prognostic factor of patient outcome and that CEP55 protein expression levels in pancreatic cancer specimens were inversely correlated with survival time by analyzing 126 archived paraffin-embedded pancreatic cancer specimens with immunohistochemical staining using an antibody against human CEP55.